Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients

Vandral Retard (Venlafaxine Extended Release) in Depressive Syndrome With Anxiety and Painful Symptoms in Elderly Patients. Observational Study in Primary Care

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00247429

Enrollment

Registered

2005-11-01

Start date

2004-07-31

Completion date

2005-10-31

Last updated

2009-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depressive Syndrome

Keywords

depression, anxiety, elderly

Brief summary

In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its effects on anxiety, somatic and painful symptoms of depression.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients older than 60 years * Depressive syndrome with associated anxiety symptoms, according to a symptoms intensity HAM-D17³14

Exclusion criteria

* Participation in other studies in the last 3 months before the start of the study * Known hypersensibility to venlafaxine * Clinically significant abnormalities according to the venlafaxine labeling

Outcome results